drugset / Trial / NCT03806556
A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study evaluates the use of tranexamic acid (TXA) in addition to standard therapy in children receiving chemotherapy or blood and/or marrow transplantation to decrease the risk of bleeding. Half of participants will receive tranexamic acid and half of participants will receive placebo.
Timeline
- Start
- 2019-04-22
- Primary completion
- 2020-08-25
- Completion
- 2020-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 10 mg/kg | Intravenous |